IRD

Opus GeneticsF

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

Peers tracked

U.S. public peers

Grade Position

Below peers

vs peer average

IRD vs peer average

21/100

IRD vs. peer average (F vs. C)

Grade spread

A 2 · B 2 · C 2 · D 2 · F 3

Graded peers loaded

Coverage

11 graded

100% of tracked

Peer overview

EDIT is the first available peer comparator.

Gene-editing therapeutics developer—comparable technology risk and regulatory pathway exposure.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerEDITEditas Medicine

IRD

Opus Genetics

EDIT

Editas Medicine

Grade

Momentum

Value

Sentiment

Setup Bias

Net —

Market Cap

Posture

Defensive

Constructive

Open Side-by-Side Comparison Compare all

Grade position vs EDIT

IRD / EDIT

Grade Position

Below peers

IRD vs. peer average (F vs. C)

21/100

Momentum

IRD

Value

IRD

Sentiment

EDIT

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs IRD

EDIT

80/100

-3

CRSP

80/100

-3

BEAM

100/100

-4

IFRX

InflaRx NV Common

20/100

Even

SNDL

SNDL Inc Common

60/100

-2

EDIT is the first peer returned for this comparison set.